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1. Introduction 
The theory has been advanced that aflatoxin Br 
(AFBr) is activated by microsomal systems to form 
aflatoxin Br 2,3-oxide [ 1,2]. This reactive metabolite 
has not been isolated and might be expected to be 
rapidly hydrolysed, either enzymically or nonenzy- 
mically, to form 2,3-dihydro-2,3-dihydroxy aflatoxin 
Br (AFBr-dhd). However, it has been reported that 
only very low levels of AFBr-dhd are formed by 
metabolism of AFBr in rat liver microsomal incuba- 
tions at pH 6.5 (2.9% conversion of AFBr using 
microsomes from phenobarbitone pre-treated rats 
and 0.6% using control microsomes) and that even 
smaller amounts of AFBr-dhd are formed at physi- 
ological pH [3]. The latter finding was ascribed to the 
destruction of AFBr-dhd at neutral pH. We here 
present evidence that AFBr-dhd is a major metabolite 
of AFBr produced by rat liver microsomes at physi- 
ological pH but it is removed by binding to microsomal 
protein. This binding does not occur at pH 6.5. 
Amines including the buffer tris-hydroxymethyl 
amino methane (Tris) and both oxidised and reduced 
glutathione can compete with microsomal protein for 
binding AFBr-dhd. Changes in the ultraviolet absorp- 
tion spectrum of AFBr-dhd indicating the formation 
of a dialdehydic phenolate ion correlate with the 
binding to amines and microsomal proteins at neutral 
pH and indicate that binding proceeds via the Schiff s 
base reaction previously suggested for the binding of 
the hemiacetal aflatoxm BZa. 
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2. Materials and methods 
2.1. Chemicals 
AFBr was obtained from Makor Chemical Co., 
Jerusalem. G- [ 3H]AFB, spec. act. 45 Ci/mmol was 
obtained from Moravek Biochemicals Ltd, City of 
Industry, CA. AFBr-dhd was prepared by reaction of 
AFBr with osmium tetroxide [5], [3H]AFB1-dhd was 
prepared by the same method using [3H]AFB, as the 
starting material. The preparation of other aflatoxins 
was as in [6]. 
Tris, glycine, and oxidised and reduced glutathione 
were AR grade obtained from Sigma (London) Chem- 
ical Co., Ltd, Poole, Dorset. Other chemicals and 
solvents used were supplied by the sources in [6]. 
2.2. AFBl metabolism 
Microsomes, prepared from the livers of adult male 
F344/TIF Lac (Fischer) rats given 0.1% phenobarbitone 
in the drinking water for 3-8 days, were incubated 
with AFBr and cofactors at 37°C in O2 with shaking 
[6]. The buffer used was either phosphate or Tris- 
HCl (both were 80 mM, pH 7.4). All procedures were 
carried out in subdued light. Metabolism was stopped 
after 30 min by the addition of 2 ml ice-cold methanol. 
After 30 min in ice the incubate was centrifuged at 
2000 rev./min and 4°C. The pellet was washed with 
2 ml ice-cold methanol and centrifuged. The combined 
supernatants were blown to dryness at 50°C under a 
stream of 02-free N,. The residue was dissolved in 
2 ml of methanol/water (1: 1, v/v), centrifuged for 
30 min at 2000 rev./min and -10°C to clarify and 
used for HPLC analysis. 
2.3. High-performance liquid chromatography (HPLC) 
A Du Pont model 830 liquid chromatograph, 833 
Elsevier/North-Holland Biomedical Press 
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flow controller, 834 automatic sampler (fitted with a 
100 ~1 injection loop) and 837 variable wavelength 
spectrophotometer (operated at 365 nm) were used. 
The fluorescence of the column eluates was monitored 
using a Kontron Spectrofiuorometer SFM 23 fitted 
with an 8 ~1 flow cell. The column used was a Partisil- 
lo-ODS (250 X 4.6 mm) obtained from Whatman 
LabSales Ltd (Maidstone) Kent, and results were 
displayed on a Hewlett-Packard model 33808 recording 
integrator. Elution of AFBl and its metabolites was 
achieved using 15% dimethylformamide in 0.01% 
phosphoric acid at 1.5 ml min-’ and a column tem- 
perature of 69°C [7]. 
2.4. Thin-layer chromatography (TLC) 
Silica gel G thin-layer plates (0.25 mm thick) were 
obtained from Anachem Ltd, Luton, Bedfordshire 
and were used without activation. Plates were devel- 
oped in either chloroform:acetone (9: 1, v/v) or 
chloroform:methanol (9: 1, v/v) and spots visualized 
by their fluorescence under long wavelength ultraviolet 
light. 
3. Results and discussion 
When aflatoxin B1 was metabolised by rat liver 
microsomes in either phosphate or Tris buffer and the 
metabolites subjected to HPLC analysis and the ultra- 
violet absorption of the eluate monitored, the chro- 
matograms shown in fig. 1 a,b were obtained. The only 
significant difference between these chromatograms 
is that a major product having a retention time of 
-6 min was present in the Tris incubations but was 
absent from the phosphate incubations. This com- 
pound had previously been identified as a degradation 
product (Tris-diol) obtained when authentic AFB1-dhd 
was treated with neutral Tris buffer [6]. The absence 
of AFB1-dhd from the phosphate incubations was 
confirmed by the parallel fluorescence monitoring of 
the HPLC eluate (excitation (Ex) 372 nm; emission 
(Em) 446 nm) (fig.lc,d). AFBI-dhd and its Tris degra- 
dation product are more highly fluorescent than 
aflatoxin B, or the other aflatoxin metabolites 
detected in these studies (fig.la,c). Despite the 
absence of the Tris-diol peak when AFBl was incuba- 
ted in phosphate buffer, the overall amounts of AFB, 
remaining unmetabolised and the rates of formation 
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Fig.1. HPLC separations of microsomal metabolites of AFB,. 
Incubations, preparations of samples and HPLC carried out 
as detailed in section 2. (a) Incubations carried out in presence 
of Tris buffer. Ultraviolet absorption of HPLC effluent moni- 
tored at 365 nm. (b) Incubations carried out in the presence 
of phosphate buffer. Ultraviolet absorption monitored at 
365 nm. (c) Incubation carried out in presence of Tris buffer. 
Fluorescence of HPLC effluent monitored at 1-x 372 nm 
Em 446 nm. (d) Incubation carried out in presence of phos- 
phate buffer. Fluorescence monitored at Ex 372 nm Em 446 nm. 
Fluorescence measurements at Ex 372 nm Em 446 nm opti- 
mal for AFB,-dhd and Tris-diol. Optima for aflatoxins B,, 
M, ahd Q, Ex 365 Em 425, but relative fluorescence of 
these aflatoxin metabolites at optimal settings essentially as 
in (c). 
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Fig.2. Rate of microsomal metabolism of AFB, and produc- 
tion of metabolites in phosphate and Tris buffer. Incubations, 
preparation of samples and HPLC carried out as detailed in 
section 2. (a) Phosphate buffer. (b) Tris-HCL buffer. 
(o) AFB,; (+) Trisdiol; (0) aflatoxin Q,; (c) atlatoxin M,; 
(a) aflatoxin P,. 
of the other metabolites were similar using the two 
buffer systems (fig.2). Paralleling the absence of Tris- 
diol metabolite from the phosphate incubations there 
was an increased binding of [3H]AFB1 to the micro- 
somes. That the binding was to microsomal protein 
was confirmed in some experiments by phenol extrac- 
tion followed by precipitation of the protein with 
acetone. Figure 3 shows the inverse relationship 
between the binding to microsomal protein and the 
amount of Tris-diol metabolite formed over a range 
of Tris concentrations. 
Authentic AFBr-dhd was found to react with 
certain compounds having an amino group (Tris and 
iso propylamine) while a related compound not having 
an amino group (1,3-propane diol) showed no reac- 
tion. Some compounds containing amino-groups, e.g., 
guanine guanosine and guanylic acid showed no reac- 
tion, presumably the pK of the amino group is of 
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Fig.3. Relationship between Trisdiol formation and protein 
binding of metabolised AFB,. Incubations, preparation of 
samples, IIPLC separations and estimation of protein binding 
as detailed in section 2. (0) Trisdiol formed; (o) AFB, 
bound. 
importance in determining the possibility of reaction 
at the pH used. The dependance of both the reaction 
of AFBr-dhd with reduced glutathione and the 
change in ultraviolet absorption spectrum of AFBi-dhd 
with pH is shown in fig.4. Oxidised glutathione yielded 
similar results. The binding of [3H]AFB1-dhd to 
microsomal protein was similarly dependent on pH 
(fig.5). 
The results presented here are probably due to the 
pH-dependent formation of a dialdehydic phenolate 
ion from AFL,-gi!:d which then undergoes Schiff s 
base reaction with amino compounds (fig.4). It has 
been suggested that aflatoxin Bza and AFBr-dhd 
undergo this pH-dependent rearrangement [4,5]. This 
hypothesis would be supported by the dependence on 
pH of binding and the bathochromic shift in ultraviolet 
absorption spectrum reported in the present study. In 
the absence of acceptor amine, it is possible to reform 
the AFBi-dhd from the dialdehydic phenolate ion by 
lowering the pH, after reaction with acceptor amine 
this reversal is not possible (G.E.N., P.J.C., unpub- 
lished results). It is probable therefore that the 
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Fig.4. Reaction of AI:B,dhd with reduced glutathione. (a) TLC of AI:B,-dhd after reaction with reduced glutathione at various 
PH values. Spots represent areas fluorescent under ultraviolet light. Developing solvent chloroform/methanol 1: 1 v/v. (b) Ultraviolet 
absorption spectra of AFB,-dhd at several pH values. Suggested pH-dependent molecular rearrangements arc also indicated. 
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Fig.5. Effect of pH on the binding of AFB,-dhd to microsomal 
protein. [3H]AFB,-dhd 12.5 nmol (IO“ dpm) and 200 ~1 
microsomal suspension in 180 mM KC1 (2.1 mg protein) 
added to 1 ml phosphate buffer at room temperature. After 
1 h, diluted 10 X with distilled water and centrifuged at 
100 000 x g for 1 h. After washing, pellet dissolved in 2 ml 
1 M NaoH at 60°C. Aliquots taken for determination of 
radioactivity. 
product of reaction between Tris and dialdehydic 
phenolate ion form of AFBr-dhd is a Schiff’s base 
adduct of these compounds, containing 1 or possibly 
2 molecules of Tris per molecule of AFBr-dhd. The 
results of this study would indicate a need for caution 
in ascribing the formation of adducts of metabolites 
of xenobiotic compounds with reduced glutathione as 
being solely due to a reaction of an electrophilic 
metabolite of the xenobiotic compound (epoxide?) 
with the nucleophilic reduced glutathione. Also care 
should be exercised when using Tris buffers in such 
systems. 
It is interesting that the reaction of AFBr-dhd with 
microsomal protein does not appear to inhibit the 
mixed function oxidase system. This is shown by the 
similarities of overall metabolism in phosphate and 
Tris buffers. Also in other experiments (G.E.N., 
P.J.C.. unpublished)we have found that if microsomal 
metabolism of AFBr is allowed to proceed in duplicate 
incubations in phosphate buffer one in the presence 
and the other in the absence of Tris for 1.5 min, and 
that Tris is then added to the incubation from which 
it was previously omitted, the subsequent rate of pro- 
duction of Tris-diol is the same in both incubations. 
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